161 related articles for article (PubMed ID: 22198862)
1. Molecular profiling of parathyroid hyperplasia, adenoma and carcinoma.
Árvai K; Nagy K; Barti-Juhász H; Peták I; Krenács T; Micsik T; Végső G; Perner F; Szende B
Pathol Oncol Res; 2012 Jul; 18(3):607-14. PubMed ID: 22198862
[TBL] [Abstract][Full Text] [Related]
2. [Changes in gene expression in the course of proliferative processes in the parathyroid gland].
Szende B; Arvai K; Peták I; Nagy K; Végsô G; Perner F
Magy Onkol; 2006; 50(2):137-40. PubMed ID: 16888677
[TBL] [Abstract][Full Text] [Related]
3. Identification of differentially expressed microRNA in parathyroid tumors.
Rahbari R; Holloway AK; He M; Khanafshar E; Clark OH; Kebebew E
Ann Surg Oncol; 2011 Apr; 18(4):1158-65. PubMed ID: 21086055
[TBL] [Abstract][Full Text] [Related]
4. Parathyroid hyperplasia, adenomas, and carcinomas: differential expression of p27Kip1 protein.
Erickson LA; Jin L; Wollan P; Thompson GB; van Heerden JA; Lloyd RV
Am J Surg Pathol; 1999 Mar; 23(3):288-95. PubMed ID: 10078919
[TBL] [Abstract][Full Text] [Related]
5. Apoptosis and P53, Bcl-2 and Bax gene expression in parathyroid glands of patients with hyperparathyroidism.
Szende B; Farid P; Végso G; Perner F; Kopper L
Pathol Oncol Res; 2004; 10(2):98-103. PubMed ID: 15188026
[TBL] [Abstract][Full Text] [Related]
6. Molecular classification of parathyroid neoplasia by gene expression profiling.
Morrison C; Farrar W; Kneile J; Williams N; Liu-Stratton Y; Bakaletz A; Aldred MA; Eng C
Am J Pathol; 2004 Aug; 165(2):565-76. PubMed ID: 15277230
[TBL] [Abstract][Full Text] [Related]
7. The presence of erythropoietin receptor in parathyroid cells.
Oztürk M; Ustek D; Akbas F; Kösem M; Abaci N; Alagöl F; Oztürk G; Kotan C
J Endocrinol Invest; 2007 Dec; 30(11):RC35-7. PubMed ID: 18250608
[TBL] [Abstract][Full Text] [Related]
8. Expression of PRAD1/cyclin D1, retinoblastoma gene products, and Ki67 in parathyroid hyperplasia caused by chronic renal failure versus primary adenoma.
Tominaga Y; Tsuzuki T; Uchida K; Haba T; Otsuka S; Ichimori T; Yamada K; Numano M; Tanaka Y; Takagi H
Kidney Int; 1999 Apr; 55(4):1375-83. PubMed ID: 10201002
[TBL] [Abstract][Full Text] [Related]
9. Identification of Differential Transcriptional Patterns in Primary and Secondary Hyperparathyroidism.
Sadowski SM; Pusztaszeri M; Brulhart-Meynet MC; Petrenko V; De Vito C; Sobel J; Delucinge-Vivier C; Kebebew E; Regazzi R; Philippe J; Triponez F; Dibner C
J Clin Endocrinol Metab; 2018 Jun; 103(6):2189-2198. PubMed ID: 29659895
[TBL] [Abstract][Full Text] [Related]
10. Selected markers of proliferation and apoptosis in the parathyroid lesions: a spatial visualization and quantification.
Kaczmarek E; Lacka K; Majewski P; Trzeciak P; Gorna A; Jarmolowska-Jurczyszyn D; Kluk A
J Mol Histol; 2008 Oct; 39(5):509-17. PubMed ID: 18726191
[TBL] [Abstract][Full Text] [Related]
11. Expression of parathyroid hormone-related protein (PTHrP) in parathyroid tissue under normal and pathological conditions.
Kitazawa R; Kitazawa S; Maeda S; Kobayashi A
Histol Histopathol; 2002 Jan; 17(1):179-84. PubMed ID: 11813867
[TBL] [Abstract][Full Text] [Related]
12. HLA Class I Expression Changes in Different Types of Cultured Parathyroid Cells.
Goncu B; Yucesan E; Aysan E; Kandas NO
Exp Clin Transplant; 2022 Sep; 20(9):854-862. PubMed ID: 30995898
[TBL] [Abstract][Full Text] [Related]
13. Expression of the antiapoptotic protein survivin in colon cancer.
Hernandez JM; Farma JM; Coppola D; Hakam A; Fulp WJ; Chen DT; Siegel EM; Yeatman TJ; Shibata D
Clin Colorectal Cancer; 2011 Sep; 10(3):188-93. PubMed ID: 21855041
[TBL] [Abstract][Full Text] [Related]
14. P53 as a marker of differentiation between hyperplastic and adenomatous parathyroids.
Ricci F; Mingazzini PL; Sebastiani V; D'Erasmo E; Letizia C; De Toma G; Alò PL
Ann Diagn Pathol; 2002 Aug; 6(4):229-35. PubMed ID: 12170454
[TBL] [Abstract][Full Text] [Related]
15. Expression of transcripts encoding a parathyroid hormone-related peptide in abnormal human parathyroid tissues.
Ikeda K; Arnold A; Mangin M; Kinder B; Vydelingum NA; Brennan MF; Broadus AE
J Clin Endocrinol Metab; 1989 Dec; 69(6):1240-8. PubMed ID: 2573615
[TBL] [Abstract][Full Text] [Related]
16. The role of hyperplasia in multiple parathyroid adenomas.
Larian B; Alavi S; Roesler J; Namazie A; Blackwell K; Calcaterra TC; Wang MB
Head Neck; 2001 Feb; 23(2):134-9. PubMed ID: 11303630
[TBL] [Abstract][Full Text] [Related]
17. Expression of nitric oxide synthases in parathyroid gland adenoma and parathyroid gland hyperplasia.
Kucera T; Veselý D; Pácová H; Martínek J; Astl J
Neuro Endocrinol Lett; 2005 Aug; 26(4):373-6. PubMed ID: 16136006
[TBL] [Abstract][Full Text] [Related]
18. Reticulin staining pattern in the differential diagnosis of benign parathyroid lesions.
Kuşku Çabuk F; Sar M; Canoğlu D; Dural C; Güneş ME
J Endocrinol Invest; 2020 Nov; 43(11):1571-1576. PubMed ID: 32242287
[TBL] [Abstract][Full Text] [Related]
19. Differential RNA expression profile by cDNA microarray in sporadic primary hyperparathyroidism (pHPT): primary parathyroid hyperplasia versus adenoma.
Velázquez-Fernández D; Laurell C; Saqui-Salces M; Pantoja JP; Candanedo-Gonzalez F; Reza-Albarrán A; Gamboa-Dominguez A; Herrera MF
World J Surg; 2006 May; 30(5):705-13. PubMed ID: 16680586
[TBL] [Abstract][Full Text] [Related]
20. A comparative study of the int-2 gene product in primary and secondary parathyroid lesions.
Tseleni-Balafouta S; Thomopoulou G; Lazaris ACh; Koutselini H; Davaris PS
Eur J Endocrinol; 2002 Jan; 146(1):57-60. PubMed ID: 11751068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
